Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB02483ExperimentalSmall molecule
Etheno-NAD: Overview.
- Formula / weight
- C23H27N7O14P2 · 687.4465 g/mol (avg)
Resolves to
Compound
Structure
InChIKey
JCDBQDNBEQHDHK-BSLNIGMPSA-NSMILES[H]N([H])C(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN2C=CN=C32)[C@@H](O)[C@H]1OTargets
What you can answer from here — as of August 31, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Etheno-NAD, and which of those have an active Phase 3 trial?